CIBC Private Wealth Group
CLBT icon

CIBC Private Wealth Group’s Cellebrite CLBT Stock Holding History

CIBC Private Wealth Group’s Portfolio CLBT Stock Details CLBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.03K Buy
+57
New +$1.02K ﹤0.01% 2909

Other funds holding CLBT

TWCM
True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
VC
Voss Capital Houston, Texas $2.15B AUM 33.46% 1-Year Est. Return
PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.81B AUM 83.9% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return

CIBC Private Wealth Group's CLBT Position: Q4 2025 in Review

CIBC Private Wealth Group opened a new position in Cellebrite (CLBT) in Q4 2025: 57 shares worth $1.03K. The stake represents ﹤0.01% of the portfolio and ranks #2909 among its holdings.

209 funds tracked by Wall St. Rank hold CLBT as of Q4 2025.

  • CIBC Private Wealth Group held 57 shares of Cellebrite worth $1.03K as of Q4 2025.
  • Cellebrite was a new CIBC Private Wealth Group position in Q4 2025.
  • Cellebrite made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2909 holding.
  • 209 funds tracked by Wall St. Rank held Cellebrite as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.